[Doctor Francoise Cathala and history of prions diseases.]
Rouen, France. In Rev Neurol (paris), May 2014
A large number of research programs were set up with numerous collaborations involving CEA (Center for Atomic Energy) and other institutions in Paris and Marseilles on epidemiology, results of tissue inoculation, electrophysiology and neuropathology of human and animal prions diseases, and resistance of the infectious agent.
Clinical applicability of multi-tumor marker protein chips for diagnosing ovarian cancer.
Zhengzhou, China. In Asian Pac J Cancer Prev, Dec 2013
MATERIALS AND METHODS: Twelve tumor markers (CA19-9, NSE, CEA, CA242, CK19, β-HCG, AFP, SCC, c-PSA, CA125, CA724 and CA15-3) were detected by protein biochip in 220 patients with ovarian carcinomas, 205 with benign ovarian tumors and 200 healthy subjects.